Kidney complications in diabetes often progress silently, putting patients at risk of life-threatening outcomes long before any symptoms appear. Identifying individuals with diabetes who are at risk ...

Kidney complications in diabetes often progress silently, putting patients at risk of life-threatening outcomes long before ...

The FDA approved pegcetacoplan (EMPAVELI; Apellis Pharmaceuticals) as the first treatment for patients aged 12 and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary ...

People with diabetes who used semaglutide or other GLP-1 agonists were also less likely to see a provider for depression.